Initial Steps in Creating a Patient-Centric Addendum to Clinical Trial Informed Consent Forms.

King-Kallimanis, Bellinda L; Ferris, Andrea; Dropkin, Lisa; Molina, Mariel; Redway, Lydia; Gerber, David E; Grant, Tracey L; Roy, Upal Basu

King-Kallimanis, Bellinda L; Ferris, Andrea; Dropkin, Lisa; Molina, Mariel; Redway, Lydia; Gerber, David E; Grant, Tracey L; Roy, Upal Basu.

Affiliation

King-Kallimanis BL; LUNGevity Foundation, Chicago, Illinois.
Ferris A; LUNGevity Foundation, Chicago, Illinois.
Dropkin L; Edge Research, Arlington, Virginia.
Molina M; Edge Research, Arlington, Virginia.
Redway L; Edge Research, Arlington, Virginia.
Gerber DE; Harold C. Simmons Comprehensive Cancer Center, University of Texas (UT) Southwestern Medical Center, Dallas, Texas.
Grant TL; LUNGevity Foundation, Chicago, Illinois.
Roy UB; LUNGevity Foundation, Chicago, Illinois.

JTO Clin Res Rep ; 4(10): 100575, 2023 Oct.

Article de En | MEDLINE | ID: mdl-37842324

Mots clés

Clinical trials; Informed consent forms; Lung Cancer; Patient-focused drug development

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: JTO Clin Res Rep Année: 2023 Type de document: Article